These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8838636)

  • 1. Biologically based, quantitative risk assessment of neurotoxicants.
    Slikker W; Crump KS; Andersen ME; Bellinger D
    Fundam Appl Toxicol; 1996 Jan; 29(1):18-30. PubMed ID: 8838636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment and neurotoxicology.
    Slikker W
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.6. PubMed ID: 20957643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicologic evidence of developmental neurotoxicity of environmental chemicals.
    Andersen HR; Nielsen JB; Grandjean P
    Toxicology; 2000 Apr; 144(1-3):121-7. PubMed ID: 10781879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPA's neurotoxicity risk assessment guidelines.
    Boyes WK; Dourson ML; Patterson J; Tilson HA; Sette WF; MacPhail RC; Li AA; O'Donoghue JL
    Fundam Appl Toxicol; 1997 Dec; 40(2):175-84. PubMed ID: 9441713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative risk assessment for developmental neurotoxic effects.
    Razzaghi M; Kodell R
    Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards quantitative risk assessment for neurotoxicity.
    Wyzga RE
    Neurotoxicology; 1990; 11(2):199-207. PubMed ID: 2234541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.
    Dorman DC; Allen SL; Byczkowski JZ; Claudio L; Fisher JE; Fisher JW; Harry GJ; Li AA; Makris SL; Padilla S; Sultatos LG; Mileson BE
    Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):101-11. PubMed ID: 11250810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to risk assessment.
    Simonsen L; Lund SP; Hass U
    Neurotoxicology; 1996; 17(3-4):815-24. PubMed ID: 9086505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmasking silent neurotoxicity following developmental exposure to environmental toxicants.
    Kraft AD; Aschner M; Cory-Slechta DA; Bilbo SD; Caudle WM; Makris SL
    Neurotoxicol Teratol; 2016; 55():38-44. PubMed ID: 27049787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro techniques for the assessment of neurotoxicity.
    Harry GJ; Billingsley M; Bruinink A; Campbell IL; Classen W; Dorman DC; Galli C; Ray D; Smith RA; Tilson HA
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):131-58. PubMed ID: 9539010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of developmental neurotoxicology studies in risk assessment.
    Tilson HA
    Toxicol Pathol; 2000; 28(1):149-56. PubMed ID: 10669002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity modeling for risk assessment.
    Kodell RL; Chen JJ; Gaylor DW
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):24-9. PubMed ID: 7494899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.
    Evangelista de Duffard AM; Duffard R
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity testing: a discussion of in vitro alternatives.
    Costa LG
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):505-10. PubMed ID: 9599699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.